Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)

Eton Pharmaceuticals' NDA for ET-400, a hydrocortisone oral solution, was accepted by the FDA with a PDUFA target action date of February 28, 2025.